{
    "Trade/Device Name(s)": [
        "CardioChek Plus Test System",
        "CardioChek Home Test System",
        "CardioChek PA Test System",
        "CardioChek PA Home Test System",
        "PTS Panels Lipid Panel test strips",
        "CardioChek Home Lipid Panel test strips"
    ],
    "Submitter Information": "Polymer Technology Systems, Inc.",
    "510(k) Number": "K151545",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140068",
        "K023558"
    ],
    "Regulatory Class": "Class I, meets the limitation of exemption 21 CFR 862.9(c)(4)",
    "Product Code(s)": [
        "CHH",
        "LBR",
        "JGY"
    ],
    "Summary Letter Date": "July 27, 2016",
    "Summary Letter Received Date": "July 29, 2016",
    "Submission Date": "December 5, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1175",
        "21 CFR 862.1475",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol (Total) test system",
        "Lipoprotein test system",
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total cholesterol",
        "HDL cholesterol",
        "Triglycerides",
        "LDL cholesterol (calculated)",
        "Chol/HDL ratio (calculated)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Capillary whole blood (fingertip)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CardioChek Plus analyzer",
        "CardioChek Home analyzer",
        "CardioChek PA analyzer",
        "CardioChek PA Home analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Reflectance photometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test System",
        "Analyzer",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for CardioChek Plus, Home, PA, and PA Home test systems and associated lipid panel test strips for quantitative measurement of cholesterol and triglycerides in whole blood",
    "Indications for Use Summary": "For quantitative determination of total cholesterol, HDL cholesterol, and triglycerides in venous and capillary whole blood for diagnosis and treatment of lipid metabolism disorders, including diabetes mellitus, atherosclerosis, and liver or renal diseases; LDL cholesterol and Chol/HDL ratios calculated by analyzer",
    "fda_folder": "Clinical Chemistry"
}